Elicio Therapeutics (ELTX) awards 60,833 stock options to its CFO
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Elicio Therapeutics, Inc. reported that Chief Strategy and Financial Officer Preetam Shah received a grant of stock options covering 60,833 shares of common stock at an exercise price of $3.20 per share. The options expire on July 16, 2036 and vest 50% on July 16, 2027 and 50% on July 16, 2028, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Shah Preetam
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 60,833 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 60,833 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 60,833 shares
Exercise price: $3.20 per share
Options held after grant: 60,833 options
+4 more
7 metrics
Stock options granted
60,833 shares
Stock option grant to Chief Strategy and Financial Officer on 2026-07-16
Exercise price
$3.20 per share
Conversion or exercise price of the granted stock options
Options held after grant
60,833 options
Total stock options reported following the transaction
Expiration date
July 16, 2036
Expiration date of the stock options granted to Preetam Shah
First vesting tranche
50% of options
Vests and becomes exercisable on July 16, 2027, first anniversary of grant
Second vesting tranche
50% of options
Vests and becomes exercisable on July 16, 2028, second anniversary of grant
Grant transaction price
$0.00 per option
Award of options reported with no cash price paid per option at grant
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"Security title listed as "Stock Option (Right to Buy)""
exercise price financial
"Conversion or exercise price of $3.2000 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The stock option vests and becomes exercisable as to 50% of the options"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"The option carries an expiration date of 2036-07-16"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
continued service financial
"Subject to the Reporting Person's continued service to the Issuer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Elicio Therapeutics (ELTX) disclose in this Form 4 for Preetam Shah?
Elicio Therapeutics disclosed that Chief Strategy and Financial Officer Preetam Shah received a stock option grant for 60,833 shares of common stock with a $3.20 exercise price, expiring on July 16, 2036, subject to a two-year vesting schedule.
What is the exercise price of the stock options granted to the ELTX CFO?
The stock options granted to Elicio Therapeutics’ Chief Strategy and Financial Officer carry an exercise price of $3.20 per share. This price applies to all 60,833 underlying common shares once the options have vested and are exercisable.
What is the vesting schedule for the 60,833 ELTX stock options granted to Preetam Shah?
The option vests in two equal installments: 50% on July 16, 2027 and 50% on July 16, 2028. Vesting is subject to Preetam Shah’s continued service to Elicio Therapeutics through each respective vesting date.
When do the newly granted ELTX stock options to Preetam Shah expire?
The stock options granted to Preetam Shah have an expiration date of July 16, 2036. Any unexercised portion of the 60,833 options will cease to be exercisable after that date, assuming they have vested under the stated schedule.